SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mastercard Inc. – ‘10-Q’ for 3/31/21 – ‘EX-31.1’

On:  Thursday, 4/29/21, at 10:12am ET   ·   For:  3/31/21   ·   Accession #:  1141391-21-91   ·   File #:  1-32877

Previous ‘10-Q’:  ‘10-Q’ on 10/28/20 for 9/30/20   ·   Next:  ‘10-Q’ on 7/29/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 5/1/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/29/21  Mastercard Inc.                   10-Q        3/31/21   95:8.9M

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.00M 
 2: EX-10.1     Material Contract                                   HTML     53K 
 3: EX-10.2     Material Contract                                   HTML     48K 
 4: EX-10.3     Material Contract                                   HTML     56K 
 5: EX-10.4     Material Contract                                   HTML     40K 
 6: EX-10.5     Material Contract                                   HTML     78K 
11: EX-99.1     Miscellaneous Exhibit                               HTML     26K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
18: R1          Cover                                               HTML     86K 
19: R2          Consolidated Statement of Operations                HTML     91K 
20: R3          Consolidated Statement of Comprehensive Income      HTML     79K 
21: R4          Consolidated Balance Sheet                          HTML    151K 
22: R5          Consolidated Balance Sheet (Parenthetical)          HTML     43K 
23: R6          Consolidated Statement of Changes in Equity         HTML     68K 
24: R7          Consolidated Statement of Cash Flows                HTML    128K 
25: R8          Summary of Significant Accounting Policies          HTML     30K 
26: R9          Acquisitions                                        HTML     45K 
27: R10         Revenue                                             HTML     56K 
28: R11         Earnings Per Share                                  HTML     40K 
29: R12         Cash, Cash Equivalents, Restricted Cash and         HTML     38K 
                Restricted Cash Equivalents                                      
30: R13         Investments                                         HTML     87K 
31: R14         Fair Value Measurements                             HTML     78K 
32: R15         Prepaid Expenses and Other Assets                   HTML     41K 
33: R16         Accrued Expenses and Accrued Litigation             HTML     35K 
34: R17         Debt                                                HTML     72K 
35: R18         Stockholders' Equity                                HTML     68K 
36: R19         Accumulated Other Comprehensive Income (Loss)       HTML     64K 
37: R20         Share-Based Payments                                HTML     34K 
38: R21         Income Taxes                                        HTML     30K 
39: R22         Legal and Regulatory Proceedings                    HTML     54K 
40: R23         Settlement and Other Risk Management                HTML     36K 
41: R24         Derivative and Hedging Instruments                  HTML     81K 
42: R25         Summary of Significant Accounting Policies          HTML     33K 
                (Policy)                                                         
43: R26         Acquisitions (Tables)                               HTML     44K 
44: R27         Revenue (Tables)                                    HTML     52K 
45: R28         Earnings Per Share (Tables)                         HTML     39K 
46: R29         Cash, Cash Equivalents, Restricted Cash and         HTML     37K 
                Restricted Cash Equivalents (Tables)                             
47: R30         Investments (Tables)                                HTML     91K 
48: R31         Fair Value Measurements (Tables)                    HTML     73K 
49: R32         Prepaid Expenses and Other Assets (Tables)          HTML     43K 
50: R33         Accrued Expenses and Accrued Litigation (Tables)    HTML     34K 
51: R34         Debt (Tables)                                       HTML     71K 
52: R35         Stockholders' Equity (Tables)                       HTML     70K 
53: R36         Accumulated Other Comprehensive Income (Loss)       HTML     63K 
                (Tables)                                                         
54: R37         Share-Based Payments (Tables)                       HTML     32K 
55: R38         Settlement and Other Risk Management (Tables)       HTML     33K 
56: R39         Derivative and Hedging Instruments (Tables)         HTML     79K 
57: R40         Acquisitions - Narrative (Details)                  HTML     47K 
58: R41         Acquisitions - Purchase Price Allocation (Details)  HTML     49K 
59: R42         Acquisitions - Identifiable Intangible Assets       HTML     38K 
                (Details)                                                        
60: R43         Revenue - Disaggregation of Revenue (Details)       HTML     52K 
61: R44         Revenue - Location on Balance Sheet of Amounts      HTML     40K 
                Recognized From Contracts With Customers (Details)               
62: R45         Revenue - Narrative (Details)                       HTML     27K 
63: R46         Earnings Per Share - Schedule of Basic and Diluted  HTML     55K 
                Earnings Per Share (Details)                                     
64: R47         Cash, Cash Equivalents, Restricted Cash and         HTML     43K 
                Restricted Cash Equivalents (Details)                            
65: R48         Investments - Investments (Details)                 HTML     32K 
66: R49         Investments - Available-for-Sale Investment         HTML     43K 
                Securities, Unrealized Gains and Losses (Details)                
67: R50         Investments - Maturity Distribution Based on        HTML     43K 
                Contractual Terms of Investment Securities                       
                (Details)                                                        
68: R51         Investments - Equity Investments (Details)          HTML     54K 
69: R52         Investments - Components of Nonmarketable           HTML     32K 
                securities (Details)                                             
70: R53         Fair Value Measurements - Distribution of           HTML     73K 
                Financial Instruments, Measured at Fair Value on a               
                Recurring Basis (Details)                                        
71: R54         Fair Value Measurements - Narrative Fair Value      HTML     33K 
                (Details)                                                        
72: R55         Prepaid Expenses and Other Assets - Schedule of     HTML     34K 
                Prepaid Expenses (Details)                                       
73: R56         Prepaid Expenses and Other Assets - Schedule of     HTML     35K 
                Other Assets (Details)                                           
74: R57         Accrued Expenses and Accrued Litigation - Accrued   HTML     36K 
                Expenses (Details)                                               
75: R58         Accrued Expenses and Accrued Litigation - Accrued   HTML     27K 
                Litigation Expense (Details)                                     
76: R59         Debt - Schedule of Long-term Debt (Details)         HTML     88K 
77: R60         Debt - Narrative (Details)                          HTML     49K 
78: R61         Stockholders' Equity - Dividends Declared           HTML     33K 
                (Details)                                                        
79: R62         Stockholders' Equity - Repurchase Authorizations    HTML     54K 
                and Purchase Activity (Details)                                  
80: R63         Stockholders' Equity - Common Stock Shares          HTML     42K 
                Activity (Details)                                               
81: R64         Accumulated Other Comprehensive Income (Loss)       HTML     73K 
                (Details)                                                        
82: R65         Share-Based Payments - Types of Equity Awards       HTML     39K 
                (Details)                                                        
83: R66         Share-Based Payments - Narrative (Details)          HTML     48K 
84: R67         Income Taxes (Details)                              HTML     27K 
85: R68         Legal and Regulatory Proceedings (Details)          HTML    129K 
86: R69         Settlement and Other Risk Management - Estimated    HTML     32K 
                Settlement Exposure (Details)                                    
87: R70         Settlement and Other Risk Management - Narrative    HTML     29K 
                (Details)                                                        
88: R71         Derivative and Hedging Instruments - Narrative      HTML     45K 
                (Details)                                                        
89: R72         Derivative and Hedging Instruments - Fair Value of  HTML     54K 
                Company's Derivative Financial Instruments                       
                (Details)                                                        
90: R73         Derivative and Hedging Instruments - Gain (Loss)    HTML     43K 
                Related to the Company's Derivative Financial                    
                Instruments Designated as Hedging Instruments                    
                (Details)                                                        
91: R74         Derivative and Hedging Instruments - Gain (Loss)    HTML     30K 
                Recognized in Income for the Contracts to Purchase               
                and Sell Foreign Currency Summary (Details)                      
93: XML         IDEA XML File -- Filing Summary                      XML    165K 
17: XML         XBRL Instance -- ma-20210331_htm                     XML   2.17M 
92: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K 
13: EX-101.CAL  XBRL Calculations -- ma-20210331_cal                 XML    277K 
14: EX-101.DEF  XBRL Definitions -- ma-20210331_def                  XML    710K 
15: EX-101.LAB  XBRL Labels -- ma-20210331_lab                       XML   1.64M 
16: EX-101.PRE  XBRL Presentations -- ma-20210331_pre                XML    988K 
12: EX-101.SCH  XBRL Schema -- ma-20210331                           XSD    187K 
94: JSON        XBRL Instance as JSON Data -- MetaLinks              397±   575K 
95: ZIP         XBRL Zipped Folder -- 0001141391-21-000091-xbrl      Zip    377K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

EXHIBIT 31.1
CERTIFICATION PURSUANT TO
RULE 13a-14(a)/15d-14(a),
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002


I, Michael Miebach, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Mastercard Incorporated for the three months ended March 31, 2021;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:April 29, 2021
By:/s/ Michael Miebach
Michael Miebach
President and Chief Executive Officer




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:4/29/218-K,  DEF 14A,  DEFA14A,  IRANNOTICE
For Period end:3/31/214
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/11/22  Mastercard Inc.                   10-K       12/31/21  140:20M
11/17/21  Mastercard Inc.                   424B2                  1:557K                                   Donnelley … Solutions/FA
11/15/21  Mastercard Inc.                   424B2                  1:542K                                   Donnelley … Solutions/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/21  Mastercard Inc.                   8-K:8,9     3/04/21   14:512K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001141391-21-000091   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 1:23:48.1am ET